Proceeds Intended to Facilitate Completion of Merger with Precipio Diagnostics During Second Quarter of 2017 OMAHA, Neb. (April 17, 2017) — Transgenomic, Inc. (OTCQB: TBIO) today reported that it has received $1.15 million in proceeds from a note bridge financing.The financing is intended to help facilitate the completion of Transgenomic’s merger with Precipio Diagnostics, LLC,... Read more
Basel, 17 April 2017 Roche announces positive interim results for emicizumab in phase III study of children with haemophilia A Emicizumab prophylaxis reduced the number of bleeds in children with haemophilia A and inhibitors to factor VIII Results build upon data for emicizumab in adults and adolescents with haemophilia A and inhibitors to factor VIII... Read more
SCIEX features its ground-breaking biologics solutions including the X500B QTOF System and the Fast Glycan Labeling and Analysis Kit April 11, 2017 Framingham, MA — SCIEX, a Danaher company and global leader in life science analytical technologies, today announced that it presented the company’s latest ground-breaking biologics solutions at the Danaher Life Sciences Biologics Day.... Read more
April 11, 2017 Shimadzu Corporation has released the pharmaceuticals impurities screening method package as a solution for use with its EDX-7000 energy dispersive X-ray fluorescence spectrometer. This package is suitable for the analysis of elemental impurities in pharmaceuticals. This package contains conditions for two methods. This enables the efficient analysis of a total of 12... Read more
Analysis with the EDX-7000 can be started by putting the sample in the special container and placing it in the instrument. There is no need to chemically pretreat the sample. Special gases and vacuum conditions are unnecessary, and since it operates on household power supply, installation is easy. In addition, by incorporating two kinds of... Read more
Chalfont St Giles, UK – 11 April 2017 – GE Healthcare has acquired Asymptote Limited, specialists in cryochain technology for sensitive cellular therapies. Asymptote’s integrated suite of cryochain hardware, software and consumables are designed to maintain the potency of cellular therapies enabling ultra-low temperature freezing during production, all the way to thawing at the clinic... Read more
Basel, 10 April 2017 Phase III study shows Roche’s Alecensa was superior to crizotinib in a specific type of lung cancer Second Phase III head-to-head study that showed that Alecensa helped people with advanced ALK-positive non-small cell lung cancer (NSCLC) Results showed that people treated with Alecensa lived significantly longer without their disease progressing compared... Read more
Preliminary Findings Indicate Potential Efficacy of Cord Blood to Improve the Lives of Children with Social and Behavioral Challenges Associated with ASD WALTHAM, Mass. – April 5, 2017– Novel research results from Duke University’s Robertson Clinical and Translational Cell Therapy Program published today in the April issue of Stem Cells Translational Medicine indicate promising developments... Read more
New Cloud-Based PerkinElmer Signals™ Notebook Helps Scientists Accelerate Drug Discovery Research WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of the PerkinElmer Signals™ Notebook at the American Chemical Society (ACS) Spring National Meeting and Exposition Booth #619 PerkinElmer’s new cloud-based Electronic Laboratory Notebook solution (ELN)... Read more
CHALFONT ST. GILES, UK and Nashville, Tennessee, USA – 3rd April 2017 – GE Healthcare has signed an agreement with HealthTrust, a group purchasing organization headquartered in Nashville, Tennessee, to provide both low energy (SPECT) and high energy (PET) radiopharmaceuticals to HealthTrust members across the United States. The agreement commenced on March 1, 2017. Marco... Read more